Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
Tuesday, July 15, 2025The Series B round saw strong participation from both existing and new investors demonstrating high industry confidence in Illimis Therapeutics vision and technology Eight existing investors including DSC Investment Woori Venture Partners Korea Devel...
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
Tuesday, July 15, 2025Merck known as MSD outside of the United States and Canada today announced the initiation of the EXPrESSIVE Phase clinical trials evaluating the safety and efficacy of MK an investigational oncemonthly
Earendil Labs announces initiation of a phase 1 study of a half-life extended novel anti-TL1A antibody
Friday, July 11, 2025Earendil Labs an AIempowered biotechnology company announced that it has completed cohort dosing in a phase trial for a novel antiTLA antibody HXN The phase study is designed to evaluate the safety
I Peace and Vita Therapeutics Launch Universal iPSC Program for FSHD Therapy
Friday, July 11, 2025Palo Alto CA Leading GMP cell CDMO I Peace Inc specializing in induced pluripotent stem cells iPSCs and iPSCderived cell therapies announced that the company has agreed with Vita Therapeutics
Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins Made in the USA
Friday, July 11, 2025Sino Biological US Inc proudly unveils ProPure an industryleading line of ultrapure endotoxinfree recombinant proteins fully produced in the USA at its stateoftheart Center for Bioprocessing CB facility in Houston
Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
Thursday, July 10, 2025Purespring Therapeutics a precision nephrology company focused on transforming the treatment of kidney diseases today announces that the US Food and Drug Administration FDA has cleared its Investigational
Zentiva and Lupin Sign License and Supply Agreement for TNF alpha inhibitor biosimilar medicine
Thursday, July 10, 2025Zentiva Group and global pharmaceutical company Lupin Limited have entered into a license and supply agreement for commercialization of Lupins biosimilar TNF alpha inhibitor medicine
Introducing the iQue® 5 HTS Platform: empowering scientists with unbeatable speed and flexibility for high throughput screening by cytometry
Thursday, July 10, 2025The life science group Sartorius launches the new iQue HighThroughput Screening HTS Cytometer transforming workflows with nextlevel flexibility and comprehensive analysis at unbeatable speeds
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
Wednesday, July 09, 2025Eton Pharmaceuticals Inc an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases today announced the Companys New Drug Application NDA for ET
BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
Wednesday, July 09, 2025Seek Labs a biotech company boldly seeking a healthier world through AIpowered discovery programmable therapeutics and pointofcare diagnostics today announced successful mapping of the Respiratory Syncytial Virus
